Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Bhp Diagnostix, Inc. — Predicate Candidate Screening
25 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
42 daysmedian FDA review time
82 days90th percentile
25clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K904503 | SERACON CR REFERENCE | Bhp Diagnostix, Inc. | 1990-11-02 | 31 | 0 |
| K863648 | SERACON CT REFERENCE | Bhp Diagnostix, Inc. | 1986-10-29 | 41 | 0 |
| K862594 | SERACON(TM) CAL (PRODUCT NO. DO35) | Bhp Diagnostix, Inc. | 1986-08-19 | 42 | 0 |
| K844927 | QUANTICEL HHR + TWO HUMAN HEMATOLOGY W/PLATELETS | Bhp Diagnostix, Inc. | 1985-03-22 | 93 | 0 |
| K844928 | QUANTICEL HHR TWO HUMAN HEMATOLOGY REFERENCE | Bhp Diagnostix, Inc. | 1985-03-22 | 93 | 0 |
| K844027 | SERACON TM SR III | Bhp Diagnostix, Inc. | 1984-11-27 | 43 | 0 |
| K844026 | SERACON TM SR IV | Bhp Diagnostix, Inc. | 1984-11-27 | 43 | 0 |
| K792486 | SERACON-SRI (PROD. # D029 | Bhp Diagnostix, Inc. | 1979-12-31 | 28 | 0 |
| K792485 | SERACON-SRI | Bhp Diagnostix, Inc. | 1979-12-31 | 28 | 0 |
| K792487 | SERACON-SRII | Bhp Diagnostix, Inc. | 1979-12-31 | 28 | 0 |
| K791958 | SERACON - EL DO27 | Bhp Diagnostix, Inc. | 1979-10-17 | 16 | 0 |
| K791957 | SERACON -LO DO26 | Bhp Diagnostix, Inc. | 1979-10-11 | 10 | 0 |
| K791956 | SERACON CAL D025 | Bhp Diagnostix, Inc. | 1979-10-11 | 10 | 0 |
| K782039 | SERACON-N | Bhp Diagnostix, Inc. | 1979-02-26 | 82 | 0 |
| K782170 | SERACON-LP | Bhp Diagnostix, Inc. | 1979-02-15 | 48 | 0 |
| K782171 | SERACON-HDL | Bhp Diagnostix, Inc. | 1979-02-08 | 41 | 0 |
| K782037 | SERACON-A | Bhp Diagnostix, Inc. | 1979-02-08 | 64 | 0 |
| K782038 | SERACON-C | Bhp Diagnostix, Inc. | 1979-02-08 | 64 | 0 |
| K781758 | SERACON-SRII | Bhp Diagnostix, Inc. | 1978-12-04 | 49 | 0 |
| K781757 | SERACON-SRI | Bhp Diagnostix, Inc. | 1978-12-04 | 49 | 0 |
| K781786 | QUANTICEL HHR # L500 AND L501 | Bhp Diagnostix, Inc. | 1978-11-15 | 27 | 0 |
| K781745 | QUANTICEL HHR, L531 AND L532 | Bhp Diagnostix, Inc. | 1978-11-15 | 26 | 0 |
| K781247 | QUANTICEL-HRP | Bhp Diagnostix, Inc. | 1978-09-14 | 55 | 0 |
| K780980 | PLATELET CONTROL | Bhp Diagnostix, Inc. | 1978-07-27 | 45 | 0 |
| K780714 | PLATELET CONTROL | Bhp Diagnostix, Inc. | 1978-06-06 | 39 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda